Competitive advantage in the biotech industry depends on several key factors: the existence
of vibrant academic institutions (Kenney 1986), venture capital and other forms of risk …

This Editorial introduces the Special Issue on 'Biotechnology Clusters and Beyond'. Drawing
on the interventions of five commissioned articles from Canada, Germany, Israel, the UK and …

We examine the evolution of biotechnology clusters in Germany between 1996 and 2003,
paying particular attention to their composition in terms of venture capital, basic science …

Today, knowledge economies are a key asset for global competitiveness. Biotechnology is a
knowledge-driven sector because it consists of knowledge working on knowledge to create …

The biotechnology industry poses a particular challenge to analysis because its origins were
poorly understood or even noticed at the time. The purpose of this paper is to examine and …

While conventional wisdom suggests that not all regions can have biotechnology, many
national science policies target it as a future growth sector. The evidence here presented …

Abstract Knowledge-intensive industries tend to concentrate geographically, because of the
many spillovers that they generate. Thus new biotechnology firms often set up in regions that …

This chapter explores what caused the clusters in US biotechnology to develop. The USA
was the first country where the biotechnology industry has flourished and the industry there …

The biotechnology industry is characterized by a network structure of interorganizational
relationships that acts as a coordination device between a variety of actors–new …

The pharmaceutical industry remains powerful due to its firm scale and global reach.
However, analysis of the source of biotechnology-derived products in healthcare, valued at …